Major League Baseball's drug testing program is among the strongest in all of sports. On Thursday, MLB Commissioner Bud Selig announced major changes, which will include in-season HGH testing.
Selig briefed top executives following the final day of Owner's Meetings on Thursday afternoon, and had a few comments regarding the change.
As I said to the owners when we announced this to the clubs, "This is a very proud day for baseball." And I believe that. This is remarkable when you think where we were 10, 12, 15 years ago and where we are today. Nobody could have dreamed it.
I just can't emphasize to you enough, when I think of all that's gone on relative to the steroids and drugs and everything. There's been a lot of conversation again the last day or two. Think of where we were and how we arrived at this day, I meant what I said. This is a proud and a great day for baseball and we'll continue to be a leader in this field and do whatever we have to do. This is good. I don't know how else to say it. This is good. This is really good.
Under the changes, players will be subject to random unannounced in-season blood tests for human growth hormone and baseline testosterone readings will be taken for all players to make it easier to detect the use of synthetic testosterone.
The more stringent procedures, which will begin this season, were implemented and announced in conjunction with the MLB Players Association and will amend the current Collective Bargaining Agreement that runs through 2016.
For more information, check out the MLB Examiner on Facebook as well as follow along on Twitter.
Comments